Brief: Mesoblast To Be Added To Nasdaq Biotechnology Index
18/12/2024 12:56
Dec 18 (Reuters) - Mesoblast Ltd MSB.AX :
* MESOBLAST TO BE ADDED TO NASDAQ BIOTECHNOLOGY INDEX
Source text: ID:nGNXc0Qfgy
Further company coverage: MSB.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Mesoblast
See all newsBrief: Mesoblast William Burns To Retire From Board At 2026 AGM
Brief: Mesoblast Says Q1 Net Revenues Up 44%
Australia's Mesoblast hits one-month high on upbeat quarterly update
Australia's Mesoblast drops as Bell Potter cuts target price after key drug misses sales view
Brief: Mesoblast Says FDA Approves New Potency Assay For Commercial Ryoncil